A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2002
10/23/2002	CN1376200A DNA vaccine-PCV
10/23/2002	CN1376148A Rate-controlled particles
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002	CN1376065A Compositions having improved stability
10/23/2002	CN1376060A Multi-component pharmaceutical dosage form
10/23/2002	CN1376059A Hydrodynamically balancing oral drug delivery system
10/23/2002	CN1376058A Oral controlled release formulations
10/23/2002	CN1376057A Anti-virus composition
10/23/2002	CN1376056A Liposome-entrapped DNA oral vaccines
10/23/2002	CN1376055A Aerosol ointment compositions and method of manufacture
10/23/2002	CN1376054A Topcial suspension formulations containing ciprofloxacin and dexa methasone
10/23/2002	CN1376043A Drug delivery of phase changing formulation
10/23/2002	CN1376042A Ophthalmic drug delivery device
10/23/2002	CN1376036A Metal-containing compositions, preparations and uses
10/23/2002	CN1375453A Heterogeneous silica as carrier material
10/23/2002	CN1375327A Plaster for treating hyperosteogeny
10/23/2002	CN1375324A Capsule for treating arthralgia of extremities and its prepn. process
10/23/2002	CN1375321A Plaster for treating hyperosteogeny, protrusion of interverterbral disc, arthritis and periarthritis of shoulder joint and its prepn.
10/23/2002	CN1375306A Sanhuanggao ointment as externally used medicine for treating burns and scalds
10/23/2002	CN1375303A Ointment for dredging meridian passage and expelling wind-evil
10/23/2002	CN1375285A Zinc glycinate capsule
10/23/2002	CN1375284A Micron level Chinese medicine tablet and its prepn
10/23/2002	CN1375283A Micro level Chinese medicine bag tea and its prepn
10/23/2002	CN1375282A Micron level Chinese medicine powder and its prepn.
10/23/2002	CN1375281A Micron level Chinese medicine capsule and its prepn.
10/23/2002	CN1375280A Micron level Chinese medicine granule and its prepn.
10/23/2002	CN1375279A Micron Chinese medicine prepn. and its prepn. process
10/23/2002	CN1375278A Micron level Chinese medicine liquid extract preparation and its preparation process
10/23/2002	CN1092995C Oil-in-water emulsifiers
10/23/2002	CN1092990C Modulation of cell proliferation and wound healing
10/23/2002	CN1092988C Thermally stabilized contrast agent
10/23/2002	CN1092986C CoA oral preparation for reducing blood fat and its preparation method and application
10/23/2002	CN1092983C Lidan (leopard cat gall) lozerge
10/23/2002	CN1092977C Anti-cancer medicine
10/23/2002	CN1092974C Chinese medicinal food
10/23/2002	CN1092973C Use of mastic or mastic lipophilia extract in preparation of drug for treatment of alzheimer's disease
10/23/2002	CN1092966C Lactobacillus ointment for treatment of vaginal diseases and preparation method therefor
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/23/2002	CN1092959C Pharmaceutical composition contg. tiagabine or receptive salt and process for its preparation
10/23/2002	CN1092957C Retarded-action microtable made of beta-phenylpropiophenone derivatives
10/23/2002	CN1092956C Sustained release drug formulation containing a tramadol salt
10/23/2002	CN1092955C Method of producing multi-layer medicaments in solid form for oral or rectal administration
10/23/2002	CN1092954C Ophthalamic compositions containing cyclotextrins and quatemary ammonium compound
10/23/2002	CA2407472A1 Sustained release compositions
10/23/2002	CA2383149A1 Process for partially reducing or eliminating the symptoms associated with the release of histamine in the body
10/23/2002	CA2383115A1 Use of an effective amount of at least one ion chelating agent to enhance the tolerance level of sensitive or intolerant skin
10/22/2002	WO2001091753A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
10/22/2002	US6469227 Antipruritic patch
10/22/2002	US6469084 Process for preparing an aqueous composition in gel form and compositions obtainable from this process, especially a composition containing vesicles, in particular liposomes
10/22/2002	US6469069 Propofol composition containing sulfite
10/22/2002	US6469062 Use of 15-keto-prostaglandins in promoting bile secretion
10/22/2002	US6469061 Use of members of the plant stress hormone family termed ?jasmonates?, for suppressing and killing mammalian cancer cells that represent major types of human malignancies
10/22/2002	US6469058 For the treatment of nonsmall cell lung cancer
10/22/2002	US6469053 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469016 Treatment of female sexual dysfunction using phosphodiesterase inhibitors
10/22/2002	US6468997 Desmethylolanzapine compositions and methods
10/22/2002	US6468994 Budesonide particles and pharmaceutical compositions containing them
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468968 Comprising a cyclosporin in a carrier medium of a fatty acid triglyceride and a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester; biavailability; side-effect reductions
10/22/2002	US6468962 Nutritional intervention composition for enhancing and extending satiety
10/22/2002	US6468961 Gel composition and methods
10/22/2002	US6468959 Dry pellets for oral or nasal administration comprising peptide drug having given net charge dispersed in matrix selected from gelatin, gelatin derivatives and/or collagen hydrolyzates having opposite charge to form pseudocoacervate
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468563 Method and device for producing pharmaceutical formulations containing an extract
10/22/2002	US6468562 Fluidity improver and/or anti-agglomeration agent, and a hydrophobic, moisture-proof layer is arranged on the surface of the particles; use in animal feeds, cosmetics and drugs
10/22/2002	US6468561 Pharmaceutical tablets, foods, confectionery forms, seeds for agriculture; polydextrose
10/22/2002	US6468560 Controlled release dosage form of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
10/22/2002	US6468559 Conditions associated with bone resorption such as osteoporosis, paget's disease, periprosthetic bone loss, osteolysis, malignant hypercalcemia, metastatic bone disease, multiple myeloma, and periodontal disease
10/22/2002	US6468558 Immunomodulating agent
10/22/2002	US6468553 Extract containing puccoon and chinese angelica
10/22/2002	US6468551 Cosmetic or dermatological preparations based on emulsifiers which are free from ethylene oxide and propylene oxide, for the preparation of microemulsion gels
10/22/2002	US6468548 Autoclavable pharmaceutical compositions containing a chelating agent
10/22/2002	US6468541 Natural, non-allergenic, immune system stimulant
10/22/2002	US6468527 Biological bioadhesive composition and methods of preparation and use
10/22/2002	US6468526 For therapy of vaginal and gastrointestinal infections
10/22/2002	US6468519 Polyanhydrides with biologically active degradation products
10/22/2002	US6468509 Sunscreen composition containing sol-gel microcapsules
10/22/2002	US6468507 Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
10/22/2002	US6468264 Closed exchange system
10/22/2002	US6468263 Implantable responsive system for sensing and treating acute myocardial infarction and for treating stroke
10/22/2002	US6467621 Package of sheet-type patches
10/22/2002	CA2406976A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
10/22/2002	CA2246754C Cochleate delivery vehicles
10/22/2002	CA2118670C Pharmaceutical compositions in semisolid form and a device for administration thereof
10/22/2002	CA2108575C Method of manufacturing solid dispersion
10/22/2002	CA2084093C Composite molecular system for the contra-escalatory treatment of viral infections
10/21/2002	WO2001087275A1 Plaster
10/21/2002	CA2407256A1 Plaster
10/17/2002	WO2002082462A2 Stabilization and terminal sterilization of phospholipid formulations
10/17/2002	WO2002082074A1 Intranasal delivery of agents for regulating development of implanted cells in the cns
10/17/2002	WO2002081662A1 Methods and gel compositions for encapsulating living cells and organic molecules
10/17/2002	WO2002081536A1 Film-forming composition for topical use and use thereof for delivering active agents
10/17/2002	WO2002081524A1 Method for producing low-viscous, aqueous cellulose ether solutions
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002081006A1 Method for eliminating potentially toxic and/or harmful substances
10/17/2002	WO2002080981A2 Polynucleotide binding complexes comprising sterols and saponins
10/17/2002	WO2002080978A2 Pharmaceutical compositions comprising ascomycin
10/17/2002	WO2002080976A2 Hsa-free formulations of interferon-beta

1 ... 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 ... 2991